Literature DB >> 12124686

Shortened fetal long bones: a possible in utero manifestation of placental function.

Yaron Zalel1, Ofer Lehavi, Eyal Schiff, Bruria Shalmon, Shlomi Cohen, Adrian Schulman, Reuven Achiron.   

Abstract

Shortened fetal long bones (SFLB) are usually indicative of a skeletal dysplasia. Our aim in this observational retrospective study was to describe a new association between SFLB, small for gestational age (SGA) fetuses and placental abnormalities, and to suggest an aetiologic explanation. During the last decade we have evaluated nine cases in which SFLB (more than 2SD below the mean) was associated with SGA, abnormal maternal serum placental hormones and abnormal placental sonography. Six cases had significantly increased second trimester maternal serum beta hCG and four developed toxaemia of pregnancy or had chronic hypertension. On histology, mature placentas with vascular abnormalities, including chorangiosis, large infarcts and slightly increased syncytial knots were noted. The combination of SFLB, SGA fetuses and placental abnormalities (sonographic, as well as histological) suggested a possible common pathway in the aetiology of this association. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12124686     DOI: 10.1002/pd.364

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  2 in total

1.  Isolated short femur length on second-trimester sonography: a marker for fetal growth restriction and other adverse perinatal outcomes.

Authors:  Katherine R Goetzinger; Alison G Cahill; George A Macones; Anthony O Odibo
Journal:  J Ultrasound Med       Date:  2012-12       Impact factor: 2.153

2.  Isolated Short Fetal Femur Length in the Second Trimester and the Association with Adverse Perinatal Outcome: Experiences from a Tertiary Referral Center.

Authors:  Mariella Mailath-Pokorny; Stephan Polterauer; Katharina Worda; Stephanie Springer; Dieter Bettelheim
Journal:  PLoS One       Date:  2015-06-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.